65,437 trials
Pain
Primary: Primary Effectiveness Endpoint: Relative Change in Numeric Rating Scale (NRS) From Baseline to 3 Months Follow-up Visit — 34.4 score on a scale — p=< 0.0001
Castration Resistant Prostatic Cancer · Metastatic Prostate Cancer
Primary: Radiographic Progression-Free Survival Rate (rPFS) at 6 Months — 0.513; 0.63 proportion of participants
Peritoneal Surface Malignancy
Primary: Dose Limiting Toxicity (DLT) — 0; 0; 0 Participants
Biceps Tendon Disorder · Tendinosis · Rotator Cuff Injuries
Primary: Comparison of American Shoulder and Elbow Surgeon (ASES) Score Between Treatment and Control Groups — 47.1; 37.1 units on a scale
Distal Radius Fracture · Distal Ulna Fracture · Osteotomy
Primary: Fracture Healing Based on Clinical Measures and X-rays — 103; 2; 10; 114 cases
Hypertension, Pulmonary
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) — 22 Participants
Solid Tumor
Primary: Determination of Maximum Tolerated Dose (MTD) or Highest Tested Dose (HTD). — 2,000,000,000 cells
Stroke · Spasticity, Muscle · CVA
Primary: Changes in the H-reflex Amplitude in Response to Nerve Stimulation
Psychology, Social · Adolescent Behavior
Primary: Behavioral: Gun Location — 50; 54; 58; 54 Participants
Movement Disorders · Parkinson Disease · Essential Tremor
Primary: Rate of MRI-related Adverse Events — 0 Percentage of participants
Obesity · Status Post Sleeve Gastrectomy
Primary: Cohen's d (the Standardized Mean Difference) — 2.145 cohen's d
Dentin Sensitivity
Primary: Adjusted Mean Change From Baseline in Schiff Sensitivity Score (Average of the Two Selected Test Teeth) at Week 12 (Test Dentifrice Versus [vs.] Negative Control)…
Food Allergy
Primary: Percentage (%) of Subjects Who Are Treatment Responders After 12 Months of EPIT Treatment. — 36.7; 49.0; 36.2; 30.2 percent of participants
Refractive Errors
Primary: Distance VA With Study Lenses at Week 1 — 95; 92; 5 eyes
Outpatient Surgery · Abdominal Surgery · Breast Surgery
Primary: Percentage of Screened Participants Who Were Eligible to Participate in the Study — 163 Participants